Abstract:For patients with early laryngeal cancer, primary radiotherapy is a well established treatment method, achieving a local control rate between 70% and more than 90% with a risk of serious toxicity of less than 2%. Including salvage surgery of irradiation failure, tumor specific survival rate is higher than 90%. In patients with moderately advanced or favorable subgroups of advanced laryngeal cancer, primary radiotherapy with some form of hyperfractionated or accelerated irradiation achieves a local control rate… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.